- Andrews PE, Young CYF, Montgomery BT, Tindall DI (1992): Tumor-promoting phorbol ester downregulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer Res 52:1525-1529.
- Bangma CH, Niemer QHJ, Grobbee DE, Schroder FH (1996): Transrectal ultrasonic volumetry of the prostate: in vivo comparison of different methods. Prostate 28:107-110.
- Behre HM, Bohmeyer J, Nieschlag E (1994): Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls. Clin Endocrinol 40:341-349.
- Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petras JA, Andriole GL (1991): Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 324:1156-1161.
- Douglas TH, Connelly RR, McLeod DG, Erickson SJ, Barren R, Murphy GP (1995): Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men. J Surg Oncol 59:246-250.
- Gormely GJ, Stoner E, Bruskewitz RC, Imperato-McGinley J, Walsh PC, McConnell JD, Andriole GL, Geller J, Bracken BR, Tenover JS (1992): The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327:1185-1191.
- Hanash KA, Mostofi KF (1992): Androgen effect on prostate specific antigen secretion. J Surg Oncol 49:202-204.
- Jackson JA, Waxman J, Spiekerman AM (1989): Prostatic complications of testosterone replacement therapy. Arch Intern Med 149:2365-2366.
- Lindau RL (1974): Does testosterone therapy for impotence increase risk of prostatic carcinoma? JAMA 229:1357-1361.
- Partin AW, Oesterling JE, Epstein JI, Horton R, Walsh PC (1991): Influence of age and endocrine factors on volume of benign prostate hyperplasia. J Urol 145:405-409.
- Roberts JT, Essenhigh DM (1986): Adenocarcinoma of prostate in 40-year-old body-builder. Lancet 2:742.
- Sasagawa I, Nakada T, Kazama T, Terada T. Katayama T (1989): Testosterone replacement therapy and prostate/seminal vesicle volume in Klinefelter's syndrome. Arch Androl 22:245-249.
- Snyder PL, Lawrence DA (1980): Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 51:1335-1339.
- Scamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N (1989): Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate, II: Radical prostatectomy treated patients. J Urol 141:1076-1083.
- Wallace EM, Pye SD, Wild SR, Wu FCW (1993): Prostate-specific antigen and prostate gland size in men receiving exogenous testosterone for male contraception. Int J Androl 16:35-40.
- Weber JF, Oesterling JE, Peters CA (1989): The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol 141:987-992.
EFFECT OF TESTOSTERONE REPLACEMENT THERAPY ON SERUM PSA IN PATIENTS WITH KLINEFELTER SYNDROME
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.